Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic Impairment
Clinical trial NCT05961397 · COMPLETED
Trial details
- NCT number
- NCT05961397
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-10
- Primary completion
- 2022-04-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.